Dr. Shapiro has consulted for various companies and institutions including:

• Albany Medical Center: A Multicenter, Double-blind, Randomized, Placebo-Controlled, Parallel Group Study to Examine the Efficacy and Safety of Meridia (Sibutramine HCl) in Binge Eating Disorder (Protocol SB 237).
• RTI-International/UNC – Chapel Hill/Agency for Healthcare Research and Quality (AHRQ). Chapel Hill, NC.Berkman ND, Bulik CM, Brownley KA, Lohr KN, Sedway JA, Rooks A, Gartlehner G. Management of Eating Disorders. Evidence Report/Technology Assessment No. 135 (Prepared by RTI International-UNC Evidence-based Practice Center under Contract No. 290-02-0016). AHRQ Publication No. 06-E010. Rockville, MD: Agency for Healthcare Research and Quality. April 2006.
• Health Informatics, Inc.
• Cellfish Media, Inc.
• Structure House, Durham, NC

Dr. Shapiro also serves as an ad hoc reviewer for several medical and psychological journals.
Finally, Dr. Shapiro is the Scientific Director at Santech, Inc., in La Jolla, CA.